APOE and Cognitive impairment: Together, these findings support a model in which APOE4 carriers are particularly susceptible to preclinical neurodegenerative changes in medial temporal regions that progress with cognitive decline, whereas among APOE4 non-carriers, microstructural changes in these regions are more closely tied to aging than cognitive impairment.